October brings the classic seasonal-transition environment, with daily temperature swings of 10°C or more and relative humidity falling sharply below 40%. Epidemiologists and respiratory physiologists describe this period as "a danger zone in which the respiratory mucosal line of defense is physiologically at its weakest." The cilia on the surface of the upper airway mucosa act as a kind of cleaning crew, pushing foreign particles and viruses out of the body. When temperatures fall below 10°C or the air stays dry, ciliary beat frequency…

October brings the classic seasonal-transition environment, with daily temperature swings of 10°C or more and relative humidity falling sharply below 40%. Epidemiologists and respiratory physiologists describe this period as "a danger zone in which the respiratory mucosal line of defense is physiologically at its weakest." The cilia on the surface of the upper airway mucosa act as a kind of cleaning crew, pushing foreign particles and viruses out of the body. When temperatures fall below 10°C or the air stays dry, ciliary beat frequency plunges by 30% to 50% or more from normal. When the mucosa dries out, tiny cracks form in the epithelial cells, creating an entry point that lets viruses bind far more easily to surface receptors (such as ACE2 and sialic acid receptors).

[Source: New York and New Jersey, DB Ban]
[Source: New York and New Jersey, DB Ban]

Epidemiological statistics also confirm how strongly October's environmental changes affect viral survival. According to experimental data from the Korea Disease Control and Prevention Agency (KDCA) and the U.S. Centers for Disease Control and Prevention (CDC), in autumn conditions where relative humidity drops below 40%, the airborne survival time of influenza and COVID-19 virus particles is extended by as much as two to three times or more compared with humidity of 60% or higher.

Infectious disease specialists warn that "October is a period of physiological and environmental double jeopardy: cold air constricts blood vessels in the nose and upper airway, limiting the movement of local immune cells (T cells and white blood cells), while more time spent in sealed indoor spaces sharply increases exposure to aerosolized viruses." This is the medical basis for why a "multidemic," in which several kinds of respiratory viruses circulate at the same time rather than a single disease simply spreading, takes hold in earnest starting in October.

Statistical Reality and Clinical Spectrum of October's Four Major Respiratory Illnesses

During the October seasonal transition, respiratory illnesses whose early symptoms look alike, including a runny nose, cough and fever, break out at the same time. However, the biological characteristics of each pathogen and the statistical threat each poses differ greatly, so precise diagnosis and differentiation are essential.

[Source: New York and New Jersey, DB Ban]
[Source: New York and New Jersey, DB Ban]
  • Influenza (flu): Caused by influenza A (H1N1, H3N2) and influenza B viruses. According to CDC clinical statistics, unlike a common cold, the flu is characterized by a sudden high fever of 38.5°C or higher, chills, headache and body-wide muscle aches. According to CDC clinical surveillance data (FluView), more than 60% of patients with severe complications during flu season are concentrated among people 65 and older and those with chronic conditions.
  • COVID-19: Since the shift to endemic status, the overall fatality rate has fallen to the level of seasonal flu (0.05% to 0.1%). However, according to KDCA's sentinel surveillance statistics on hospitalized patients, people 65 and older account for roughly 60% to 65% of all COVID-19 hospitalizations. In particular, clinical studies have shown that in cases of "co-infection" with influenza and COVID-19 at the same time, the risk of progressing to severe illness and the fatality rate can rise by as much as six times compared with a single infection, so high-risk groups need to be cautious.
  • Respiratory syncytial virus (RSV): A virus that is especially dangerous for infants and toddlers age 2 and under and for adults 65 and older. It begins with mild cold-like symptoms, but when the virus reaches the bronchioles, it causes wheezing and difficulty breathing. It accounts for more than 50% of hospitalizations for bronchiolitis and pneumonia in infants and toddlers. Pediatric specialists stress that "if a child's chest sinks in below the ribs when breathing, emergency care is needed immediately."
  • Mycoplasma pneumonia: A bacterial respiratory illness that tends to cause major outbreaks in cycles of three to four years. According to Health Insurance Review and Assessment Service (HIRA) statistics, out of about 1.88 million pneumonia patients treated annually, mycoplasma pneumonia accounts for 10% to 30% of all pneumonia cases among children, including school-age children (ages 6 to 12). It is characterized by a fever of 38°C or higher along with a paroxysmal, phlegm-producing cough lasting two to three weeks or longer. It does not respond to ordinary penicillin-class antibiotics, so after a precise PCR diagnosis, macrolide or quinolone antibiotics must be carefully prescribed.

3. Vaccine-Based Prevention: Effectiveness of Co-Administration and Environmental Health Guidelines

[Source: New York and New Jersey, DB Ban]
[Source: New York and New Jersey, DB Ban]

The core medical defense against respiratory illness in October is the combined implementation of "receiving new seasonal vaccines" and "managing indoor air quality." Because it takes about two weeks after vaccination for protective antibodies to form, the ideal time to get vaccinated is between mid- and late October, before the winter surge begins in earnest.

According to immunization guidelines from the Korean Society of Infectious Diseases and the CDC, "co-administration of the flu vaccine and the updated COVID-19 variant vaccine" is strongly recommended for high-risk groups, including adults 65 and older, people with chronic conditions (diabetes, cardiovascular disease, chronic respiratory disease) and pregnant women. Analysis of large-scale CDC clinical data has verified that even when the two vaccines are given on the same day in different arms, there is no difference in immunogenicity (antibody formation rate) or safety compared with separate administration. On the contrary, co-administration has been shown to reduce the number of visits to vaccination sites, improving adherence, and to lower severe hospitalization rates from the twindemic by 40% to 60% or more.

Managing the indoor environment is also a medical measure needed to maintain the body's mucosal line of defense.

  • Keep humidity at 40% to 60%: When indoor humidity falls below 40%, ciliary movement in the mucosa is impaired. Use a humidifier or wet towels to maintain proper humidity, and drink at least 1.5 liters of lukewarm water a day in small amounts to preserve the moisture layer of the respiratory epithelial cells.
  • Ventilate on a set schedule: According to KDCA indoor air quality guidelines, opening windows on opposite sides to create cross-ventilation for 10 minutes at least three times a day can reduce the concentration of airborne viruses and aerosols indoors by more than 80%.
  • Personal hygiene: Wearing a KF80 or higher health mask and washing hands with soap under running water for at least 30 seconds after coming home are proven physical defenses that block the contact transmission route of viruses.
[Source: New York and New Jersey, DB Ban]
[Source: New York and New Jersey, DB Ban]

The Early "Golden Time" for Infection and Clinical Guidelines by High-Risk Group

When symptoms of respiratory infection such as fever, sore throat and cough appear, the key to preventing severe illness is "early diagnosis within 48 hours of symptom onset and tailored antiviral treatment." If people dismiss it as a simple cold, misuse or overuse combination cold medicines and miss the treatment window, the risk rises that the virus will reach the lower airway and progress to complications such as secondary bacterial pneumonia.

As soon as symptoms begin, it is recommended to visit a medical facility right away and get a combination rapid antigen test that can distinguish influenza from COVID-19 at the same time.

  1. If influenza is confirmed: Antivirals such as Tamiflu (oseltamivir) or Xofluza (baloxavir) must be given within 48 hours of symptom onset to suppress viral replication and shorten the period of high fever.
  2. If COVID-19 is confirmed in a high-risk patient: Antivirals such as Paxlovid or Lagevrio (molnupiravir) must be started within five days of symptom onset to dramatically lower the risk of severe hospitalization and death.
  3. If mycoplasma pneumonia is diagnosed: Pediatric infectious disease specialists urge that, to prevent drug-resistant bacteria, a precise bacterial genetic test (PCR) be performed first and then a targeted antibiotic be given in the exact dose.

When caring for a child or an older patient, take them immediately to the emergency room of a major hospital if any of the following "red flags" appear.

  • A high fever of 39°C or higher lasts three days or more despite fever reducers, or improves and then rises again
  • Breathing rate increases sharply, and chest pain or severe chest retractions are seen when breathing
  • Cyanosis, in which the lips, tongue or fingertips turn blue, or signs of low oxygen saturation appear
  • Consciousness declines, or the patient shows extreme lethargy or seizures
[Source: New York and New Jersey, DB Ban]
[Source: New York and New Jersey, DB Ban]

Seasonal respiratory infections can be well controlled through advance vaccination, science-based environmental management and accurate, precise diagnosis within the early golden time. Taking proactive steps in line with expert guidance is the surest key to a healthy winter.

Summary of Medical Statistics, Prevention and Response Guidelines for Major October Respiratory Illnesses
IllnessMain Pathogen and Clinical FeaturesKey Statistics and Risk IndicatorsPrevention and Vaccine GuidelinesGolden Time and Treatment After Infection
Influenza (flu)Influenza A/B viruses; sudden high fever of 38.5°C or higher, chills, muscle achesMore than 60% of patients with severe complications are concentrated among people 65 and olderGet a flu shot in October, wear a mask, wash handsAntivirals (Tamiflu, etc.) within 48 hours of symptom onset
COVID-19SARS-CoV-2 variants; sore throat, cough, fever, changes in taste and smell60% to 65% of hospitalized patients are older adults; fatality rate up to six times higher with flu co-infection2025-2026 updated variant vaccine (co-administration with flu shot recommended)Take an antiviral drug (Paxlovid) within 5 days of symptom onset
RSV (Respiratory Syncytial Virus)RSV virus; wheezing, bronchiolitis, difficulty breathingAccounts for more than 50% of hospitalizations for bronchiolitis and pneumonia in infants and young childrenWash hands, disinfect toys, keep indoor humidity at 40–60%Treatment focuses on relieving symptoms; immediate hospitalization if chest retractions or cyanosis occur
Mycoplasma PneumoniaMycoplasma pneumoniae bacteria; paroxysmal cough with phlegm lasting 2–3 weeks or longerAccounts for 10–30% of pneumonia cases among school-age children, out of 1.88 million pneumonia patients treated each yearPractice cough etiquette and personal hygiene, and ventilate indoor spacesPCR test followed by targeted antibiotics such as macrolides

© NY&NJ. Unauthorized reproduction and redistribution prohibited

ⓒ New York and New Jersey. Unauthorized reproduction and redistribution are prohibited.